InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
83%
T+90 mean return
-0.0%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Larsen Glenn R., Director. Director active across 2 companies, notably Anika Therapeutics, Inc.. Aggregated, 7 disclosures have been published. History available since 16 June 2021. The latest transaction was disclosed on 20 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations7 total
14,164 shares0Common StockSEC:0001171843-25-004070:0
5,771 shares0Common StockSEC:0001171843-24-003908:0
6,500 shares0Common StockSEC:0001171843-23-003960:0
7,954 shares0Common StockSEC:0001171843-22-004300:0
4,172 shares0Common StockSEC:0001171843-21-004428
4,172 shares0Common StockSEC:0001171843-21-004428:0
2,361 sharesCommon StockSEC:0001171843-16-007718:0
7 of 7 declarations
About Larsen Glenn R.
Glenn R. Larsen is a Board Member at Anika Therapeutics, Inc. He contributes to the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is valuable in guiding the company's initiatives. As a board member, he ensures that Anika meets its performance and innovation objectives.
